Načítá se...
Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
Bronchodilation with muscarinic antagonists, β(2)-agonists, and inhaled corticosteroids remains the foundation of pharmaceutical treatment for patients with stable COPD. These drugs are delivered from a variety of devices, including dry powder inhalers, pressurized metered-dose inhalers, soft-mist i...
Uloženo v:
| Vydáno v: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927563/ https://ncbi.nlm.nih.gov/pubmed/31908443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S157654 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|